A Study in Participants With Type 2 Diabetes Mellitus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 978 participants.

Also called NCT01064687

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 978 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01064687
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Mexico, Puerto Rico (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01064687. Randomized; quadruple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-11 (actual). Results posted on 2015-01-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study in Participants With Type 2 Diabetes Mellitus
Acronym
AWARD-1
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
LY2189265
Intervention (Drug)
Exenatide
Intervention (Drug)
Placebo
Intervention (Drug)
Metformin
Intervention (Drug)
Pioglitazone
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct01064687
Content hash
fa5d45695713b30775710e1ab2e040b5514d5fd1c065ea64a26bb490e280c808